Chargement en cours...
Management of specialty drugs, specialty pharmacies and biosimilars in the United States
Background: Specialty medicines continue to increase as a percentage of spending with biologics representing a large portion of specialty spending. Health plans expect to adjust their formularies to maximize expected savings from biosimilars. Objectives: A better understanding of health plan managem...
Enregistré dans:
| Publié dans: | J Drug Assess |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6764408/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21556660.2019.1658331 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|